Public Defence: Jacob Andreas Winther Jacob Andreas Winther at Institute of Clinical Medicine will be defending the thesis “Prognostic and diagnotsic biomarkers linked to water and sodium regulation in acute dyspnea” for the degree of PhD (Philosophiae Doctor).

Trial Lecture – time and place

See Trial Lecture.

Adjudication committee

  • First opponent: Professor Alexandre Mebazaa, Hôpital Lariboisière, Université Paris Diderot
  • Second opponent: Associate Professor Alessandro Peri, University of Florence
  • Third member and chair of the evaluation committee: Professor Anne Cathrine Staff, University of Oslo

Chair of the Defence

Associate Professor Stephan Brackmann, University of Oslo

Principal Supervisor

Professor Torbjørn Omland, University of Oslo


Biomarkers related to water and sodium regulation, such as B-type natriuretic peptides (BNPs), provide clinically useful information with regards to prognosis and diagnosis, especially in patients with heart failure (HF). Chronic obstructive pulmonary disease (COPD), currently the third most common cause of death globally, is also associated with changes in water and sodium regulation, but the value of these biomarkers in the COPD setting is uncertain.

The aim of this thesis was to determine the prognostic and diagnostic value of hyponatremia and two novel biomarkers, specifically copeptin and mid-regional-proANP (MR-proANP), in patients admitted to hospital with acute dyspnea. Sodium and biomarker concentrations were measured on admission, and the cause of dyspnea was diagnosed by an adjudication committee. Survival was recorded after a median follow-up of 2.2 years, and the association between biomarkers and mortality was assessed. Subgroup analysis was performed in patients with acute HF and acute exacerbation of COPD (AECOPD).

Hyponatremia was prevalent in acute dyspnea regardless of whether the cause of dyspnea was acute HF or AECOPD. Hyponatremia was associated with increased mortality in acute HF but not in AECOPD. Copeptin and MR-proANP, on the other hand, were independently associated with mortality in both acute HF and AECOPD. The prognostic accuracy of copeptin and MR-proANP were comparable to the amino terminal fragment of BNP (NT-proBNP) in acute HF and superior to NT-proBNP in AECOPD. Concerning diagnostic properties, copeptin and MR-proANP concentrations were increased in acute HF compared to other causes of dyspnea, but only MR-proANP matched the diagnostic accuracy of NT-proBNP. Thus, copeptin and MR-proANP shows great potential, especially as prognostic biomarkers in acute HF and AECOPD.

Additional information

Contact the research support staff.

Published May 29, 2019 3:44 PM - Last modified May 29, 2019 3:50 PM